GBIP India 2024
Microbira at GBIP India, June 2024 In June 2024, Microbira participated in Innovate UK's Global Business Innovation Programme (GBIP) focused on Antimicrobial Resistance (AMR) in India. This initiative allowed us…
Microbira at GBIP India, June 2024 In June 2024, Microbira participated in Innovate UK's Global Business Innovation Programme (GBIP) focused on Antimicrobial Resistance (AMR) in India. This initiative allowed us…
Microbira at GBIP Switzerland, May 2023 We are very excited to announce our selection and participation in Innovate UK's Global Business Innovation Programme (GBIP) in Switzerland. This initiative focused on Antimicrobial…
Microbira delivering a lecture on AI Innovation at System C, February 2024 Watch Marianne Ismail, CEO of Microbira, as she explores how AI innovation rapidly detects and identifies infectious microorganisms…
Microbira at the 33rd ECCMID Copenhagen, presenting rapid microorganism identification, Denmark 15-18 April 2023 annual conference Marianne Ismail, CEO of Microbira, opened the Diagnostics Pipeline Corner at ECCMID in Denmark.…
Delivering medical device software solutions with Microbira Microbira, a UK-based company founded in 2019, enhances healthcare delivery using artificial intelligence (AI) and Fourier Transform Infrared (FTIR) spectroscopy. These technologies enable…
Newcastle scientists help develop one-of-a-kind tool to detect infections like Strep A and E. coli Scientists at a Newcastle laboratory have played a key role in supporting the development of…
North East Innovation Lab: Expanding the artificial intelligence system's database by providing reference microorganisms The Microbira project supports new artificial intelligence techniques to diagnose infection and improve patient outcomes.The system…